We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$907M
AUM Growth
+$111M
Cap. Flow
+$61.4M
Cap. Flow %
6.78%
Top 10 Hldgs %
99.88%
Holding
12
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$30.9M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$30.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$690M 76.11%
1,202,804
+55,825
+5% +$30.9M
INDA icon
2
iShares MSCI India ETF
INDA
$6.89B
$142M 15.65%
2,425,144
– –
VEU icon
3
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$32M 3.53%
+507,600
New +$30.6M
FHTX icon
4
Foghorn Therapeutics
FHTX
$266M
$14.7M 1.62%
1,573,761
– –
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.15B
$10.1M 1.12%
989,410
– –
ALEC icon
6
Alector
ALEC
$168M
$6.09M 0.67%
1,307,858
– –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$59.2M
$3.92M 0.43%
2,627,643
– –
ME
8
DELISTED
23andMe Holding Co
ME
$3.59M 0.4%
512,156
– –
TNYA icon
9
Tenaya Therapeutics
TNYA
$161M
$1.96M 0.22%
1,015,705
– –
RAPT
10
DELISTED
RAPT Therapeutics
RAPT
$1.32M 0.15%
82,237
– –
SRZN icon
11
Surrozen
SRZN
$258M
$1.05M 0.12%
87,696
– –
SRZNW icon
12
Surrozen Inc Warrant
SRZNW
$1.76K ﹤0.01%
170,833
– –

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return

Euclidean Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Euclidean Capital held 12 positions worth $907M, up 14% from $796M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital deployed $61.4M of net new capital in Q3 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 507,600 shares worth $32M.

By sector, the portfolio is most concentrated in Healthcare at 4.7% of assets, up from 4.6% a quarter earlier.

  • Euclidean Capital's largest Q3 2024 buy was Vanguard FTSE All-World ex-US ETF: 507,600 shares worth $32M.
  • Euclidean Capital added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $30.9M increase.
  • Euclidean Capital's ten largest holdings make up 100% of its $907M portfolio in Q3 2024.
  • Euclidean Capital opened 1 new position and closed 0 in Q3 2024.
  • Euclidean Capital's portfolio value rose 14% quarter-over-quarter to $907M.

Based on Euclidean Capital's 13F filing for Q3 2024, filed 14 Nov 2024.